Xilio Therapeutics Inc (XLO) - Koefisien rega marang bathi

Lambang korporat lan logo Xilio (XLO)

Xilio Therapeutics, Inc. (XLO) generates revenue through the creation of specific cytokines, with the market launch of safe immuno-oncology agents serving as the primary growth driver. However, financial stability depends on payments from Gilead, while R&D expenditures result in losses; the current figure stands at -4.40. The share price history reflects the asset's price action. Xilio Therapeutics, Inc. (XLO) minimizes side effects by activating molecules within neoplasms, expanding access to therapy for severe pathologies.

xiliotx.com (XLO): Rasio rega marang bathi saka 04.07.2022 nganti 17.11.2026

Rincian analitis perusahaan Xilio Therapeutics (XLO)

Ringkesan analisis perusahaan:Xilio Therapeutics, Inc.
Produk asli xiliotx.com

Xilio Therapeutics, Inc. (XLO) competes in a high-tech sector where specialized cold-chain logistics costs for drugs directly impact margins. By analyzing the company's P/E ratio history, an investor determines the capital payback period through the ratio of market value to net income, which allows for the identification of asset overvaluation or a fundamental undervaluation relative to industry peers.

Analisis perusahaan pesaing

ONC: Nilai perusahaan marang bathi resik|Koefisien rega marang bathi HALO (Halozyme Inc.)|RVMD (RevMed) - Nilai perusahaan marang bathi resik|Pangali P/E AAPG (ascentage.com)|CGON - Koefisien rega marang bathi|URGN: Koefisien rega marang bathi|BCAX - Pangali P/E|Personalis Corp (PSNL) - Rasio rega marang bathi|Erasca Corp - Nilai perusahaan marang bathi resik|DCTH (Delcath Systems Inc) - Pangali P/E|Kapitalisasi marang bathi Y-mAbs Therapeutics, Inc. YMAB|Pangali P/E AURA|Koefisien rega marang bathi Candel Therapeutics, Inc. CADL|Pangali P/E ARAY (Accuray, Inc.)|SELLAS Life Sciences - Rasio rega marang bathi|ACTU: Koefisien rega marang bathi|Citius Oncology, Inc. - Rasio rega pasar marang bathi resik|HURA (TuHURA Biosciences) - Koefisien rega marang bathi|TARA: Rasio rega pasar marang bathi resik|Koefisien rega marang bathi FATE|WHWK: Nilai perusahaan marang bathi resik|Koefisien rega marang bathi TCRX (TScan Therapeutics Inc)|Periode bali modal bisnis Champions Oncology Inc|Pangali P/E XBIT (XBiotech Inc.)|Nilai perusahaan marang bathi resik CVM|OS Therapies Inc. - Pangali P/E|RADX - Pangali P/E|ARTV: Pangali P/E|ANL: Rasio rega pasar marang bathi resik|Koefisien rega marang bathi VERU|TPST: Nilai perusahaan marang bathi resik|Rasio rega marang bathi Enochian BioSciences (RENB)|Rasio rega marang bathi MURA (Mural Oncology PLC)|Rasio rega marang bathi Kairos Pharma Ltd KAPA|Pangali P/E OnKure Therapeutics Inc OKUR|CytoMed Therapeutics - Pangali P/E|Periode bali modal bisnis Curis CRIS|APLM: Pangali P/E|Koefisien rega marang bathi Tharimmune, Inc.|ADVB (Advanced Biomed) - Pangali P/E|Genprex - Kapitalisasi marang bathi resik|Rasio rega marang bathi calidibio.com (CLDI)|SBFM (Sunshine Biopharma Inc.) - Nilai perusahaan marang bathi resik|Pangali P/E XBIO (Xenetic Biosciences)|Salarius Pharmaceuticals (SLRX) - Kapitalisasi marang bathi|PPBT: Koefisien rega marang bathi|Nilai perusahaan marang bathi resik AONC (American Oncology Network, Inc.)|BeOne Medicines (BGNE) - Rasio rega marang bathi|Checkpoint Therapeutics, Inc (CKPT) - Pangali P/E|Rasio rega marang bathi Elevation Oncology, Inc.|ICAD: Nilai perusahaan marang bathi resik|Rasio rega marang bathi ikenaoncology.com (IKNA)|Rasio rega marang bathi NTBL (Notable Labs, Ltd.)|Pangali P/E VIRX (viracta.com)|MOR - Koefisien rega marang bathi|NAYA - Rasio rega marang bathi|Kapitalisasi marang bathi resik AAPGV